Hello and welcome to the details of Colombia grants emergency use for J&J coronavirus vaccine and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
BOGOTA, March 26 — Colombia has approved emergency use of Johnson & Johnson’s one-shot Covid-19 vaccine, the director of food and drug regulator Invima said as part of a government address yesterday.
The approved vaccine is developed by Janssen, the pharmaceutical wing of Johnson & Johnson.
“In its capacity as regulator, Invima has authorised the emergency use of the vaccine from the pharmaceutical company Janssen, of the multinational Johnson & Johnson,” INVIMA director Julio Cesar Aldana said during the government’s nightly broadcast.
In addition to being a one-dose vaccine, the J&J vaccine has less demanding storage needs than some other approved vaccines, Aldana said.
Colombia has also closed agreements for vaccines developed by Pfizer Inc and BioNTech, AstraZeneca , Moderna, and Sinovac. It is also set to receive doses via the World Health Organization-backed Covax mechanism.
Colombia has also so-far approved use of the vaccines developed by Pfizer and BioNTech, AstraZeneca and Sinovac.
The government has reached an agreement to buy nine million doses of J&J’s one-shot vaccine.
Colombia hopes to vaccinate around 70 per cent of its population in a bid to achieve herd immunity.
The country has recorded over 2.35 million cases of coronavirus and more than 62,500 deaths. It has administered more than 1.38 million vaccine doses. — Reuters
These were the details of the news Colombia grants emergency use for J&J coronavirus vaccine for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.